Brief: Celcuity Reports Clinical Data From Two Early Phase Studies Of Gedatolisib
30/06/2025 12:26
June 30 (Reuters) - Celcuity Inc CELC.O: CELCUITY REPORTS CLINICAL DATA FROM TWO EARLY PHASE STUDIES OF GEDATOLISIB CELCUITY INC - PHASE 1 TRIAL SHOWS 66% SIX-MONTH RPFS RATE IN MCRPC CELCUITY INC - PHASE 2 TRIAL SHOWS 43% ORR IN HER2+ MBC Source text: ID:nGNX5WrxXV Further company coverage: CELC.O (((( Reuters.briefs@thomsonreuters.com ;));))